Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a new definition of decompensated cirrhosis
Gennaro D’Amico, Mauro Bernardi, Paolo Angeli
Journal of Hepatology (2021) Vol. 76, Iss. 1, pp. 202-207
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

EASL Clinical Practice Guidelines on acute-on-chronic liver failure
Richard Moreau, Marta Tonon, Aleksander Krag, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 461-491
Open Access | Times Cited: 126
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2
Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C
Eiichi Ogawa, Nicholas Chien, Leslie Y. Kam, et al.
JAMA Internal Medicine (2022) Vol. 183, Iss. 2, pp. 97-97
Open Access | Times Cited: 51
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
Lorenz Balcar, Marta Tonon, Georg Semmler, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100513-100513
Open Access | Times Cited: 49
Diabetes and cirrhosis: Current concepts on diagnosis and management
Laurent Castéra, Kenneth Cusi
Hepatology (2023) Vol. 77, Iss. 6, pp. 2128-2146
Closed Access | Times Cited: 38
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis
Marta Tonon, Roberta D’Ambrosio, Valeria Calvino, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 4, pp. 603-609
Open Access | Times Cited: 27
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC
Suzanne R. Sharpton, Rohit Loomba
Hepatology (2023) Vol. 78, Iss. 6, pp. 1896-1906
Open Access | Times Cited: 26
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers
Jonel Trebicka, Rubén Hernáez, Debbie L. Shawcross, et al.
Gut (2024) Vol. 73, Iss. 6, pp. 1015-1024
Open Access | Times Cited: 11
Acute and non‐acute decompensation of liver cirrhosis (47/130)
Martin S. Schulz, Paolo Angeli, Jonel Trebicka
Liver International (2024)
Open Access | Times Cited: 9
Preventing the progression of cirrhosis to decompensation and death
Cándid Villanueva, Dhiraj Tripathi, Jaime Bosch
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
Prognostic assessment of liver cirrhosis and its complications: current concepts and future perspectives
Dilan Gülcicegi, Tobias Goeser, Philipp Kasper
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 15
Noninvasive assessment of hepatic decompensation
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 14
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0
Alberto Zanetto, Filippo Pelizzaro, Monica Mion, et al.
United European Gastroenterology Journal (2023) Vol. 11, Iss. 9, pp. 815-824
Open Access | Times Cited: 13
One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis
Florent Artru, Thomas Reiberger
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 537-539
Open Access | Times Cited: 5
Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor
Linzhang Zhang, Jiewen Shi, Qin Shen, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116833-116833
Closed Access | Times Cited: 12
Compensated liver cirrhosis: Natural course and disease-modifying strategies
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash
World Journal of Methodology (2023) Vol. 13, Iss. 4, pp. 179-193
Open Access | Times Cited: 12
Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
Shuyue Tuo, Yee Hui Yeo, Rachel Huai‐En Chang, et al.
Clinical Nutrition (2023) Vol. 43, Iss. 1, pp. 84-94
Closed Access | Times Cited: 11
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis
Marcello Dallio, Mario Romeo, Paolo Vaia, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 685-704
Open Access | Times Cited: 4
Efficacy of fresh frozen plasma transfusion in decompensated cirrhosis patients with coagulopathy admitted to ICU: a retrospective cohort study from MIMIC-IV database
Xiangjie Fu, Danyang Yan, Wan‐Ting Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
The prevalence and characteristics of frailty in cirrhosis patients: a meta-analysis and systematic review
Ruiyu Xie, Xiaotong Jing, Chuan-Jie Yang
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: Stratifying the impact of add‐on fibrates in real‐world practice
Elena Góméz, J.L. Montero, Ezequiel Molina, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 12, pp. 1604-1615
Open Access | Times Cited: 4
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP)—A single center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Asieb Sekandarzad, Erika Graf, Eric Peter Prager, et al.
Artificial Organs (2024) Vol. 48, Iss. 10, pp. 1150-1161
Open Access | Times Cited: 4
Physiological network approach to prognosis in cirrhosis: A shifting paradigm
Tope Oyelade, Kevin P. Moore, Ali R. Mani
Physiological Reports (2024) Vol. 12, Iss. 13
Open Access | Times Cited: 4
Clinical implications of inflammation in patients with cirrhosis
Victoria Kronsten, Debbie L. Shawcross
The American Journal of Gastroenterology (2024) Vol. 120, Iss. 1, pp. 65-74
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top